A couple of things for me: - No mention of MS (surprising considering they mentionned it last conference call) - 3 arms (High/Low/Placebo) for Rett - Still no clarity on genetic differences between responders and non-responders (analyses marked as NOW) - No firm timelines
A lot of the info is not new. But then again, we are not the target audience, this is for folks who've never heard about Anavex first.